Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 2, 2009, Pages 420-421

  Laurent, Frederic ^a   Tristan, A ^a   Croze, M ^a   Bes, M ^a   Meugnier, H ^a   Lina, G ^a   Vandenesch, F ^a   Etienne, J ^a  

^a HOSPICES CIVILS DE LYON   (France)

Author keywords

Impetigo; Skin and soft tissue infections; Toxin

Indexed keywords

BACTERIAL TOXIN; EXFOLIATIVE TOXIN B; FUSIDIC ACID; GENE PRODUCT; PROTEIN FUSB; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATION; COMMUNITY ASSESSMENT; EPIDEMIC EUROPAN FUSIDIC ACID RESISTANT IMPETIGO CLONE; FRANCE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; IMPETIGO; LETTER; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; SKIN DISEASE; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS;

EID: 58849090943     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn456     Document Type: Letter

References (5)

1. Denton M, O'Connell B, Bernard P et al. The EPISA study: antimicrobial susceptibility of Staphylococcus aureus causing primary or secondary skin and soft tissue infections in the community in France, the UK and Ireland. J Antimicrob Chemother 2008; 61: 586-8.
2. O'Neill AJ, Larsen AR, Skov R et al. Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol 2007; 45: 1505-10.
3. Tveten Y, Jenkins A, Kristiansen BE. A fusidic acid-resistant clone of Staphylococcus aureus associated with impetigo bullosa is spreading in Norway. J Antimicrob Chemother 2002; 50: 873-6.
4. O'Neill AJ, Chopra I. Molecular basis of fusB-mediated resistance to fusidic acid in Staphylococcus aureus. Mol Microbiol 2006; 59: 664-76.
5. Larsen AR, Skov RL, Jarlier V et al. Epidemiological differences between the UK and Ireland versus France in Staphylococcus aureus isolates resistant to fusidic acid from community-acquired skin and soft tissue infections. J Antimicrob Chemother 2008; 61: 589-94.